Literature DB >> 20184883

CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).

Janka Held-Feindt1, Kirsten Hattermann, Susanne Sebens Müerköster, Hanna Wedderkopp, Friederike Knerlich-Lukoschus, Hendrik Ungefroren, H Maximilian Mehdorn, Rolf Mentlein.   

Abstract

The transmembrane chemokine CX3CL1 and its receptor CX3CR1 are thought to be involved in the trafficking of immune cells during an immune response and in the pathology of various human diseases including cancer. However, little is known about the expression and function of CX3CR1 in human glioma-infiltrating microglia/macrophages (GIMs), representing the major cellular stroma component of highly malignant gliomas. Here, we show that CX3CR1 is overexpressed at both the mRNA and protein level in solid human astrocytomas of different malignancy grades and in glioblastomas. CX3CR1 was localized in ionized calcium-binding adapter molecule 1 (Iba1) and CD11b/c positive GIMs in situ as shown by fluorescence microscopy. In accordance with this, freshly isolated human GIM-enriched fractions separated by CD11b MACS technology displayed high Iba1 and CX3CR1 mRNA expression levels in vitro. Moreover, cultured human GIMs responded to CX3CL1-triggered activation of CX3CR1 with adhesion and migration in vitro. Besides an increase in motility, CX3CL1 also enhanced expression of matrix metalloproteases 2, 9, and 14 in GIM fractions in vitro. These data indicate that the CX3CL1/CX3CR1 system has a crucial tumor-promoting role in human glioblastomas via its impact on glioma-infiltrating immune subsets. Copyright 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184883     DOI: 10.1016/j.yexcr.2010.02.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  51 in total

Review 1.  Targeting specific cells in the brain with nanomedicines for CNS therapies.

Authors:  Fan Zhang; Yi-An Lin; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  J Control Release       Date:  2015-12-11       Impact factor: 9.776

2.  An miR-340-5p-macrophage feedback loop modulates the progression and tumor microenvironment of glioblastoma multiforme.

Authors:  Yunyun Liu; Xiaoyu Li; Yuanpei Zhang; Hongxuan Wang; Xiongming Rong; Jialing Peng; Lei He; Ying Peng
Journal:  Oncogene       Date:  2019-08-19       Impact factor: 9.867

3.  Microglia in the tumor microenvironment: taking their TOLL on glioma biology.

Authors:  David H Gutmann
Journal:  Neuro Oncol       Date:  2014-12-18       Impact factor: 12.300

4.  Pinocembrin protects hemorrhagic brain primarily by inhibiting toll-like receptor 4 and reducing M1 phenotype microglia.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Qiang Li; Yufeng Gao; Tian Cheng; Jieru Wan; Wei Zhu; Jian Wang
Journal:  Brain Behav Immun       Date:  2016-12-20       Impact factor: 7.217

5.  NKG2D ligands in glioma stem-like cells: expression in situ and in vitro.

Authors:  Charlotte Flüh; Guranda Chitadze; Vivian Adamski; Kirsten Hattermann; Michael Synowitz; Dieter Kabelitz; Janka Held-Feindt
Journal:  Histochem Cell Biol       Date:  2018-01-22       Impact factor: 4.304

6.  Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.

Authors:  Grant W Simmons; Winnie W Pong; Ryan J Emnett; Crystal R White; Scott M Gianino; Fausto J Rodriguez; David H Gutmann
Journal:  J Neuropathol Exp Neurol       Date:  2011-01       Impact factor: 3.685

7.  Neurofibroma-associated macrophages play roles in tumor growth and response to pharmacological inhibition.

Authors:  Carlos E Prada; Edwin Jousma; Tilat A Rizvi; Jianqiang Wu; R Scott Dunn; Debra A Mayes; Jose A Cancelas; Eva Dombi; Mi-Ok Kim; Brian L West; Gideon Bollag; Nancy Ratner
Journal:  Acta Neuropathol       Date:  2012-10-26       Impact factor: 17.088

8.  S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages.

Authors:  Huaqing Wang; Leying Zhang; Ian Y Zhang; Xuebo Chen; Anna Da Fonseca; Shihua Wu; Hui Ren; Sam Badie; Sam Sadeghi; Mao Ouyang; Charles D Warden; Behnam Badie
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

Review 9.  The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment.

Authors:  Elizabeth A Stoll; Philip J Horner; Robert C Rostomily
Journal:  Aging Cell       Date:  2013-06-28       Impact factor: 9.304

10.  Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.

Authors:  A Ellert-Miklaszewska; P Wisniewski; M Kijewska; P Gajdanowicz; D Pszczolkowska; P Przanowski; M Dabrowski; M Maleszewska; B Kaminska
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.